11

Feb2019

Expensive Drugs for Rare Diseases – Provincial Working Group Consultation

In keeping with our continuing efforts to support transparency and share input submissions for public policy consultations, PDCI is hosting responses to a recent CADTH survey that was conducted on behalf of the Provincial/Territorial (P/T) Expensive Drugs for Rare Disease Working Group (EDRD WG). The EDRD WG sought public feedback ... Read More

07

Feb2019

CADTH Launches New Parallel Scientific Advice Program

On February 6, 2019, CADTH announced a new collaboration with England’s NICE (National Institute for Health and Care Excellence) to offer Parallel Scientific Advice to pharmaceutical companies. Participating pharmaceutical companies will receive advice simultaneously from CADTH and NICE to facilitate evidence generation for the Canadian and English markets. This new opportunity ... Read More

04

Feb2019

Observations on National Pharmacare from John-Paul Dowson

Observations on National Pharmacare from John-Paul Dowson, PDCI’s Director of Reimbursement Strategy.

17

Jan2019

Status Summary of Negotiations on Brand Name Drugs as of December 31, 2018

The Office of the pan-Canadian Pharmaceutical Alliance (pCPA) assesses brand name drug products for public funding either collectively or individually at the provincial and territorial levels. Each month the pCPA issues an update on the previous month’s negotiation activity. A file is complete once a Letter of Intent (LOI) is ... Read More

08

Jan2019

All 2019 HDAP Meeting Dates Released

The PMPRB has announced the rest of the 2019 meeting dates to the Human Drug Advisory Panel (HDAP)’s calendar for 2019, bringing to the total meetings up to four (4), as per previous years. HDAP Meeting Patentee Submission Deadline Monday, February 25th, 2019 Thursday, November 29th, 2018 Monday, May 27th, ... Read More

20

Dec2018

CADTH Releases Pharmaceutical Review Update Issue 4

New updates from pCODR are as follows: Webinar on Clinician Input and Feedback Seminar CADTH is hosting a webinar in collaboration with Innovation Medicines Canada (IMC) on January 22nd, 12:00 pm to 1:00 pm EST, to provide detailed information about this process and new tools being offered for clinicians. This webinar ... Read More

19

Dec2018

Holiday Greetings

12

Nov2018

New INESSS Website Launched

INESSS has launched a modernized website that is more user-friendly and provides greater transparency. Some of the highlighted new features includes: Enhanced search engine that allows broader searches throughout the full website and that offers additional Advance Search filters. New Social Services, Drugs and Health Services sections which provide new ... Read More

02

Nov2018

PMPRB October 2018 NEWSletter Released

PMPRB has released its October 2018 NEWSletter which includes updates on Guideline Reform and PMPRB’s timelines for its Guidelines modernization initiative. Updates on Guideline Reform Consultations with stakeholders have progressed more slowly than anticipated, due to conflicting views amongst participants and complexity of reforms. A January 2019 implementation date for the ... Read More

23

Oct2018

Register for the Market Access Summit and Save 20% with PDCI

On November 12-13th, the Market Access Summit will be chaired by PDCI’s Kaitlyn Proulx, Managing Director and John-Paul Dowson, Director, Reimbursement Strategy. We are so excited to see you there that we want to offer you a 20% discount. That’s not ... Read More